Drug · DIN 02434849
TEVA-ALMOTRIPTAN
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since December 12, 2014; first marketed December 12, 2014.
- Drug Identification Number (DIN)
- 02434849
- Company (DIN owner)
- Teva Canada LimitedToronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Almotriptan N02CC05
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ALMOTRIPTAN (ALMOTRIPTAN MALATE) | 12.5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- December 12, 2014: NOC 16434Abbreviated New Drug Submission (ANDS)